These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12511595)

  • 1. Novel transglutaminase inhibitors reverse the inflammation of allergic conjunctivitis.
    Sohn J; Kim TI; Yoon YH; Kim JY; Kim SY
    J Clin Invest; 2003 Jan; 111(1):121-8. PubMed ID: 12511595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel anti-inflammatory peptides from the region of highest similarity between uteroglobin and lipocortin I.
    Miele L; Cordella-Miele E; Facchiano A; Mukherjee AB
    Nature; 1988 Oct; 335(6192):726-30. PubMed ID: 2971881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of antiflammins on transglutaminase and phospholipase A2 activation by transglutaminase.
    Moreno JJ
    Int Immunopharmacol; 2006 Feb; 6(2):300-3. PubMed ID: 16399636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic applications of antiflammin peptides in experimental ocular inflammation.
    Chan CC; Tuaillon N; Li Q; Shen DF
    Ann N Y Acad Sci; 2000; 923():141-6. PubMed ID: 11193752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucosamine is an effective chemo-sensitizer via transglutaminase 2 inhibition.
    Kim DS; Park KS; Jeong KC; Lee BI; Lee CH; Kim SY
    Cancer Lett; 2009 Jan; 273(2):243-9. PubMed ID: 18804908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New target against inflammatory diseases: transglutaminase 2.
    Kim SY
    Arch Immunol Ther Exp (Warsz); 2004; 52(5):332-7. PubMed ID: 15507874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Peptide with anti-transglutaminase activity decreases lipopolysaccharide-induced lung inflammation in mice.
    Suh GY; Ham HS; Lee SH; Choi JC; Koh WJ; Kim SY; Lee J; Han J; Kim HP; Choi AM; Kwon OJ
    Exp Lung Res; 2006; 32(1-2):43-53. PubMed ID: 16809220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DP2 (CRTh2) antagonism reduces ocular inflammation induced by allergen challenge and respiratory syncytial virus.
    Stebbins KJ; Broadhead AR; Musiyenko A; Barik S; Scott JM; Truong YP; Stearns BA; Hutchinson JH; Prasit P; Evans JF; Lorrain DS
    Int Arch Allergy Immunol; 2012; 157(3):259-68. PubMed ID: 22042170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of transglutaminase 2 inhibition with glucosamine: implications of a possible anti-inflammatory effect through transglutaminase inhibition.
    Jeong KC; Ahn KO; Lee BI; Lee CH; Kim SY
    J Cancer Res Clin Oncol; 2010 Jan; 136(1):143-50. PubMed ID: 19655169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transglutaminase 2 induces nitric oxide synthesis in BV-2 microglia.
    Park KC; Chung KC; Kim YS; Lee J; Joh TH; Kim SY
    Biochem Biophys Res Commun; 2004 Oct; 323(3):1055-62. PubMed ID: 15381106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetic analysis of the interaction of tissue transglutaminase with a nonpeptidic slow-binding inhibitor.
    Case A; Stein RL
    Biochemistry; 2007 Jan; 46(4):1106-15. PubMed ID: 17240993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and evaluation of peptidic maleimides as transglutaminase inhibitors.
    Halim D; Caron K; Keillor JW
    Bioorg Med Chem Lett; 2007 Jan; 17(2):305-8. PubMed ID: 17092716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the synthesis of platelet-activating factor by anti-inflammatory peptides (antiflammins) without methionine.
    Tetta C; Camussi G; Bussolino F; Herrick-Davis K; Baglioni C
    J Pharmacol Exp Ther; 1991 May; 257(2):616-20. PubMed ID: 2033508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic inhibition of transglutaminase-induced cross-linking of Alzheimer's amyloid beta-peptide.
    Zhang W; Johnson BR; Bjornsson TD
    Life Sci; 1997; 60(25):2323-32. PubMed ID: 9194688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of novel dipeptide-bound 1,2,4-thiadiazoles as irreversible inhibitors of guinea pig liver transglutaminase.
    Marrano C; de Macédo P; Gagnon P; Lapierre D; Gravel C; Keillor JW
    Bioorg Med Chem; 2001 Dec; 9(12):3231-41. PubMed ID: 11711299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding to PLA2 may contribute to the anti-inflammatory activity of catechol.
    Dileep KV; Tintu I; Mandal PK; Karthe P; Haridas M; Sadasivan C
    Chem Biol Drug Des; 2012 Jan; 79(1):143-7. PubMed ID: 21995306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel transglutaminase inhibitors reduce the cornified cell envelope formation.
    Kim SY; Park WM; Jung SW; Lee J
    Biochem Biophys Res Commun; 1997 Apr; 233(1):39-44. PubMed ID: 9144392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiflammins: endogenous nonapeptides with regulatory effect on inflammation.
    Moreno JJ
    Gen Pharmacol; 1997 Jan; 28(1):23-6. PubMed ID: 9112072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-activity relationship study of novel tissue transglutaminase inhibitors.
    Duval E; Case A; Stein RL; Cuny GD
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1885-9. PubMed ID: 15780627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Participation of transglutaminase in the activation of latent transforming growth factor beta1 in aging articular cartilage.
    Rosenthal AK; Gohr CM; Henry LA; Le M
    Arthritis Rheum; 2000 Aug; 43(8):1729-33. PubMed ID: 10943862
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.